Leena Patel | President and CEO
Patient Access Network Foundation

Leena Patel, President and CEO, Patient Access Network Foundation

Leena Patel oversees donor relations and development at the Patient Access Network Foundation. As the Director of Development, Ms. Patel maintains the day-to-day communications with PAN’s donors, and also maintains existing and identifying new disease fund opportunities. Prior to joining the PAN Foundation, Ms. Patel was a Health Policy Associate at Applied Policy, where she worked with clients to understand and navigate the complexities of health policy and reimbursement issues.

Appearances:



Pharma Pricing & Market Access USA Day 1 @ 12:50

ROUND TABLES

1) US payer introduction to the structures and processes

  • Jennifer L. Bragg, Partner, FDA regulatory and litigation attorney
  • Asif Velani, Head of Market Access, Puma Biotechnology
2) Statistical methodologies- learning new meta analysis techniques
  • Andy Gunn, Global Head Evidence Generation, UCB BioPharmaceuticals Inc
  • Simon Semus, Observational Data Analyst, GSK
3) Policy framework- Patient data and evidence management
  • Amy Niles, Vice President, External Affairs, Patient Access Network Foundation
  • Leena Patel, President and CEO, PAN Foundation
4) Economic Evaluation of Vaccines- Providing value through the prevention of disease
  • David Davidovic, Former Vice President & Global Head, Commercial Services, Roche & Genentech
5) Value Frameworks - What is the future?
  • Christine Verini, Chief Business Development Officer, CancerCare
  • John Stoeckle, Physician, Thomas Jefferson University Hospitals, Inc
  • Susan Gabriel, Director, Global Health Economics and Outcomes Research, Teva Pharmaceuticals
6) Biosimilars - Market Access
  • Jennifer Voelker, HEOR fellow, Janssen
  • Sonia Lee, HEOR fellow, Ethicon
  • Ravi Iyer, Director Global Health Economics and Reimbursement, Teva
  • Ying Wu, Director HEOR, Teva
  • Ravi Iyer, Director Global Health Economics and Reimbursement, Teva
7) BioBetter Pricing Models- Discovering how biobetters are becoming mainstream
  • Boxiong Tang, Sr. Director, GHEOR, Teva
  • Riad Dirani, Vice President Global Health Economics & Outcomes Research & EBM Global Medical Affairs, Teva Pharmaceuticals
8) Dynamic Drug Pricing Frameworks- Converging supply and demand Uber style
  • Ben Locwin, Ex-Executive Director, Roche
9) EHR records- How to bennefit 
  • Yong Chen, Director of Real World Data & Analytics, GSK
10) Post Release Commercialization - When and how
  • Shailesh Chavan, Vice President, Clinical Research, Drug Safety & Medical Affairs, Biotest Pharmaceuticals

 

Policy framework- Patient data and evidence management

back to speakers